Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. [electronic resource]
Producer: 20100520Description: e8688 p. digitalISSN:- 1932-6203
- Arachidonic Acids -- pharmacology
- Base Sequence
- Camphanes -- pharmacology
- Cell Proliferation -- drug effects
- Cytokines -- metabolism
- DNA Primers
- Endocannabinoids
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry
- Humans
- Microscopy, Confocal
- Piperidines -- pharmacology
- Polyunsaturated Alkamides -- pharmacology
- Pyrazoles -- pharmacology
- Receptor, Cannabinoid, CB2 -- agonists
- Reverse Transcriptase Polymerase Chain Reaction
- Rimonabant
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.